Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1141908

	registered interest
	date	24/07/2019
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Armed Forces
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government by how much (1) the Royal Navy, (2) the army, and (3) the Royal Air Force, are under strength.
	tabling member printed	Lord Campbell of Pittenweem
	uin	HL17452
	answer	answer is ministerial correction date of answer 02/08/2019 answer text <p>The current strength of the Armed Forces as at 1 April 2019 is give<ins class="ministerial">n</ins> in the table below:</p><p> </p><table><tbody><tr><td><p>Service</p></td><td><p>Trained Strength</p></td><td><p>Workforce Requirement</p></td></tr><tr><td><p>Royal Navy/Royal Marines</p></td><td><p>29,224</p></td><td><p>30,568</p></td></tr><tr><td><p>Army</p></td><td><p>75,070</p></td><td><p>82,000</p></td></tr><tr><td><p>Royal Air Force</p></td><td><p>30,010</p></td><td><p>31,756</p></td></tr></tbody></table><p>Trained Strength comprises military personnel who have completed Phase 1 and 2 training for Royal Navy/Royal Marines, the Army (prior to 1 October 2016) and the Royal Air Force. Following the change in definition of trained strength for Army, from 1 October 2016, trained strength for the Army comprises of personnel who have completed Phase 1 training.</p><p>The Ministry of Defence remains committed to maintaining the overall size of the Armed Forces and we have a range of measures under way to improve recruitment and retention. The challenge is kept under constant review.</p><p>Importantly the Services continue to meet all their current commitments, keeping the country and its interests safe.</p><p> </p><p>The strength of the Armed Forces is published every three months and can be found in the UK Armed Forces Quarterly Service Personnel Statistics at the following link:</p><p> </p><p>https://www.gov.uk/government/statistics/quarterly-service-personnel-statistics-2019</p> answering member printed Baroness Goldie question first answered 02/08/2019 13:21:39 question first ministerially corrected 20/08/2019 11:14:54 answering member 4306 label Biography information for Baroness Goldie previous answer version 132042 answering member printed Baroness Goldie answering member 4306 label Biography information for Baroness Goldie
	tabling member	627 label Biography information for Lord Campbell of Pittenweem

1141704

	registered interest
	date	24/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much each clinical commissioning group has spent on child and adolescent mental health services in each year since 2013.
	tabling member constituency	Harborough
	tabling member printed	Neil O'Brien
	uin	281781
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Information on spend on mental health provision for children and young people aged 0-25, by clinical commissioning group is not available prior to 2016/17. Details of spend for 2016/17, 2017/18 and 2018/19 is set out in the attached table. This includes spend on eating disorders but excludes spend on learning disabilities.</p><p>This information is included in the Mental Health Five Year Forward View Dashboard, published by NHS England, which is available at the following link:</p><table><tbody><tr><td><p><a href="https://www.england.nhs.uk/mental-health/taskforce/imp/mh-dashboard/" target="_blank">https://www.england.nhs.uk/mental-health/taskforce/imp/mh-dashboard/</a></p></td></tr></tbody></table><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 09/09/2019 17:34:25 question first ministerially corrected 10/09/2019 10:42:53 answering member 1481 label Biography information for Ms Nadine Dorries attachment 1 file name PQ281781 attachment formatted.xlsx title CAMHS Spend since 2013 previous answer version 135787 answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4679 label Biography information for Neil O'Brien

1141959

	registered interest
	date	24/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Clinical Trials
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government which clinical trials are currently recruiting patients with HER2+ breast cancer.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL17503
	answer	answer is ministerial correction date of answer 07/08/2019 answer text <p>The Department’s National Institute for Health Research (NIHR) is currently recruiting to 15 clinical trials for people with HER2+ breast cancer via its Clinical Research Network. The majority of these are commercially funded. To date, a total of 7,986 participants have been recruited to these 15 trials.</p><p>Of the 15 clinical trials, 12 are commercially sensitive, with appropriate cost recovery from the companies. The data for these commercial trials has been provided from the relevant companies as ‘commercial in confidence’ hence we are unable to provide details about these trials such as their titles.</p><p>However, the three clinical trials which are not commercially sensitive are:</p><p>- Cancer Research UK; NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC). Title: The UK plasma based Molecular profiling of Advanced breast cancer to inform Therapeutic Choices (plasmaMATCH);</p><p>- Cancer Research UK. Title: Response to Optimal Selection of neo-adjuvant Chemotherapy in Operable breast cancer; and</p><p>- Medical Research Council. Title: A mechanistic non-invasive imaging study of HER2 expression in breast cancer using [18F]GE-226 positron emission tomography.</p> answering member printed Baroness Blackwood of North Oxford question first answered 07/08/2019 11:43:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1141958

	registered interest
	date	24/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pertuzumab
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what advice they provide to clinicians for the use of Pertuzumab rather than Herceptin for the treatment of HER2+ breast cancer.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL17502
	answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for making recommendations for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources.</p><p>NICE has recommended the following drugs for the treatment of HER2-positive breast cancer: trastuzumab emtansine (Kadcyla) for treating HER2-positive advanced breast cancer after trastuzumab (Herceptin) and a taxane; pertuzumab (Perjeta) with trastuzumab (Herceptin) and docetaxel for treating HER2-positive breast cancer; pertuzumab (Perjeta) for the neoadjuvant treatment of HER2-positive breast cancer; and pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer.</p><p>NHS commissioners are legally required to fund drugs recommended in NICE technology appraisal guidance. It is for clinicians to decide on the most appropriate treatment for an individual patient based on their clinical judgement and in discussion with the patient.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17501 question first answered 25/07/2019 16:45:03 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1141957

	registered interest
	date	24/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what are the drugs approved by NICE to treat HER2+ breast cancer; and what assessment they have made of the efficacy of such drugs.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL17501
	answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for making recommendations for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources.</p><p>NICE has recommended the following drugs for the treatment of HER2-positive breast cancer: trastuzumab emtansine (Kadcyla) for treating HER2-positive advanced breast cancer after trastuzumab (Herceptin) and a taxane; pertuzumab (Perjeta) with trastuzumab (Herceptin) and docetaxel for treating HER2-positive breast cancer; pertuzumab (Perjeta) for the neoadjuvant treatment of HER2-positive breast cancer; and pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer.</p><p>NHS commissioners are legally required to fund drugs recommended in NICE technology appraisal guidance. It is for clinicians to decide on the most appropriate treatment for an individual patient based on their clinical judgement and in discussion with the patient.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17502 question first answered 25/07/2019 16:45:03 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1141956

	registered interest
	date	24/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Illness: Children
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of reports that referrals to child mental health units from primary schools for pupils aged 11 and under have risen by almost 50 per cent in the last three years.
	tabling member printed	Lord Watson of Invergowrie
	uin	HL17500
	answer	answer is ministerial correction date of answer 07/08/2019 answer text <p>No formal assessment has been made as comparable data is not available at a national level.</p><p>Referral data for children and young people’s mental health services is published by NHS Digital in the Mental Health Services Dataset since 2017. This shows that in 2017/18 there were 259,615 new referrals to children and young people’s mental health services for people aged 0-18 and 381,528 new referrals for the same in 2018/19.</p><p>The number of providers supplying data has increased in 2018/19 and so a direct comparison between the two years is not possible.</p> answering member printed Baroness Blackwood of North Oxford question first answered 07/08/2019 11:38:28 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1241 label Biography information for Lord Watson of Invergowrie

1141955

	registered interest
	date	24/07/2019
	answering body	Department for Education
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Schools: Standards
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of any relationship between the proportion of disadvantaged pupils attending a school and the likelihood of that school receiving a good or outstanding Ofsted rating; and what steps they intend to take as a result of any such assessment.
	tabling member printed	Lord Watson of Invergowrie
	uin	HL17499
	answer	answer is ministerial correction date of answer 02/08/2019 answer text <p>The department has not conducted an assessment of the relationship between the proportion of disadvantaged pupils attending a school and its likelihood of being rated by Ofsted as good or outstanding.</p><p>Schools are allocated additional funding, in the form of the pupil premium, for pupils on roll who are classed as disadvantaged. Pupils are classed as disadvantaged through having been registered for free school meals at any point in the last 6 years, being looked after or having left care through adoption or other specified routes. Schools have flexibility over the ways in which they use this funding to improve the attainment and other outcomes of their disadvantaged pupils and these can include measures to improve the quality of teaching received by those pupils. Ofsted will also consider how leaders and governors spend the pupil premium, their rationale and the intended impact, as part of school inspection.</p><p> </p> answering member printed Lord Agnew of Oulton question first answered 02/08/2019 12:16:04 answering member 4689 label Biography information for Lord Agnew of Oulton
	tabling member	1241 label Biography information for Lord Watson of Invergowrie

1141954

	registered interest
	date	24/07/2019
	answering body	Department for Digital, Culture, Media and Sport
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	hansard heading	Artificial Intelligence: Business
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to encourage more UK companies to automate decision-making through artificial intelligence technology.
	tabling member printed	Lord Taylor of Warwick
	uin	HL17498
	answer	answer is ministerial correction date of answer 02/08/2019 answer text <p>Artificial intelligence and automation present enormous opportunities for our economy. Some studies suggest that artificial intelligence could add 10% to the UK GDP by 2030. Other studies highlight the benefits that artificial intelligence and automation could bring to specific sectors.</p><p> </p><p>For example, the independent “Made Smarter” review, published in October 2017, estimated that digital technologies, such as robotics, artificial intelligence, and additive manufacturing, could add £455bn to the UK manufacturing economy over the next decade.</p><p> </p><p>For that reason, under our modern Industrial Strategy, we have taken the following steps to support automation where and when it is appropriate and is for the betterment of society:</p><p> </p><ul><li>£558m of the £1.7bn Industrial Strategy Challenge Fund is related to automation;</li><li>Investment across UKRI partners for robotics, autonomous systems and AI for physical systems since 2014 totals £366m and has attracted a further £153m leverage from private sector or other public bodies;<br></li><li>The AI Sector Deal, published in April 2018, is worth up to£950m and is already delivering pioneering skills and data initiatives to create the jobs and markets of tomorrow; <br></li><li>Government is backing Made Smarter as our key industrial digitalisation programme, including through up to £121m investment into the Made Smarter digital manufacturing challenge to increase manufacturing productivity by up to 30%;</li><ul><li>In addition, Government is investing £20m into the Made Smarter North West pilot for adoption of digital technology, which includes robotics and automation;</li><li>Growth Hubs provide an important one stop shop for businesses seeking to improve their productivity. The £20m Made Smarter North-West Pilots will engage 3,000 SME manufacturers across the north west to improve their productivity, administered through Growth Hubs; and <br></li></ul><li>The UK’s Catapult network helps bridge the gap between businesses and the expertise of the UK’s world-class research in automation. In August 2018, Government committed a further £780m over the next 5 years, which will be match funded with over £1.5bn in industry R&amp;D.</li></ul><p> </p> answering member printed Baroness Barran question first answered 02/08/2019 12:13:54 answering member 4703 label Biography information for Baroness Barran
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1141953

	registered interest
	date	24/07/2019
	answering body	Department for Digital, Culture, Media and Sport
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	hansard heading	Internet: EU Action
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of EU plans for a Digital Services Act after Brexit.
	tabling member printed	Lord Taylor of Warwick
	uin	HL17497
	answer	answer is ministerial correction date of answer 02/08/2019 answer text <p>Member States have not yet been consulted on EU plans for a Digital Services Act. We look forward to seeing the details of this proposal when it is published.</p> answering member printed Baroness Barran question first answered 02/08/2019 12:13:28 answering member 4703 label Biography information for Baroness Barran
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1141952

	registered interest
	date	24/07/2019
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Merchant Shipping: Security
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have, if any, to join a United States-led shipping coalition after Brexit.
	tabling member printed	Lord Taylor of Warwick
	uin	HL17496
	answer	answer is ministerial correction date of answer 02/08/2019 answer text <p>The UK is part of ongoing conversations with international allies, including the US on how best we can ensure maritime security in the Gulf and protect freedom of navigation. This is not connected to the United Kingdom's departure from the European Union.</p><p> </p><p>Freedom of navigation is in every nation's interest; it is unacceptable to illegally seize a ship going about legitimate business in an internationally recognised shipping lane. Any action we take will be aimed at ensuring freedom of navigation is maintained.</p><p> </p><p>We continue to work for stability in the region with the international community, and to uphold the international rules that protect us all.</p><p> </p> answering member printed Baroness Goldie question first answered 02/08/2019 12:11:18 answering member 4306 label Biography information for Baroness Goldie
	tabling member	1796 label Biography information for Lord Taylor of Warwick